Skip to main content

Table 5 Multivariable Mortality Model

From: Incremental prognostic value of echocardiography of left ventricular remodeling and diastolic function in STICH trial

VariablesWald Chi SquareDFP valueHazard Ratio (95% CI)
Creatinine (1.0–1.6; Δ1mg/dL)30.01< 0.0013.21 (2.11, 4.86)
LVESVI (> 65; Δ10 cc/m2)27.31< 0.0011.09 (1.06, 1.33)
Age (> 57; Δ10 yr)20.31< 0.0011.35 (1.19, 1.55)
Treatment (CABG/ CABG +SVR vs. MED)13.11< 0.0010.71 (0.59, 0.85)
E/A ratio12.42< 0.001 
E/A ≤ 0.6 (Δ0.1)1.410.2370.89 (0.73, 1.08)
E/A 0.6–2.3 (Δ0.1)12.41< 0.0011.03 (1.01, 1.04)
NYHA (I, II, III, IV)7.310.0071.18 (1.05, 1.34)
Diabetes (yes or no)6.210.0131.27 (1.05, 1.54)
History of Stroke (yes or no)6.210.0131.49 (1.09, 2.04)
MR severity (CFI grade)6.110.0141.15 (1.03, 1.29)
History of atrial fibrillation/flutter (yes or no)4.210.0411.34 (1.01, 1.78)
Hemoglobin (≤14.3Δ 1 g/dL)3.210.0760.94 (0.88, 1.01)
  1. EF Ejection fraction, LVESVI Left ventricular end systolic volume index, MR Mitral regurgitation, LA Left atrium, RV Right ventricle, CABG Coronary artery bypass grafting, SVR Surgical ventricular reconstruction